SOURCE: StockCall

StockCall

October 15, 2010 08:52 ET

Research on Rite Aid Corp. and CVS Caremark Corporation - Better Future According to Drug Stores Industry Players

JOHANNESBURG, SOUTH AFRICA--(Marketwire - October 15, 2010) -  www.stockcall.com/ offers investors comprehensive research on the drug stores industry and has completed analytical research on Rite Aid Corp. (NYSE: RAD) and CVS Caremark Corporation (NYSE: CVS). Register with us today at www.stockcall.com/ to have free access to these researches. 

It has been a rocky year for many in the drug store industry. Reforms to the healthcare industry alongside the sluggish economy have led to mixed financial readings so far this year, with many companies posting declines in earnings. Despite lower sales figures industry players are investing heavily in their futures and currently footing the bill for starting up new programs. As the healthcare and consumer landscape is changing around them, companies are looking to expand their services to stay ahead in the long-term. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the drug stores industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the drug stores industry can have easy and free access to our analyst research and opinions on Rite Aid Corp. and CVS Caremark Corporation; investors and shareholders of these companies can simply register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html

Some like Rite Aid Corp. are developing partnerships with grocers, whereby their stores now offer a wider range of products including low priced fresh foods. Those which also provide insurance are focusing on expanding the role of the pharmacy and pharmacist in healthcare, so as to provide a more complete service to their customers. Investors can register for free to access the research report on Rite Aid Corp. at www.stockcall.com/RAD151010.pdf.

Although figures for this year, and some say even for 2011, look uninspiring, members of the industry claim the future looks bright. With the federal expansion providing more Americans with healthcare coverage and American baby boomers reaching retirement age, it is anticipated that demand for prescriptions in the U.S. would be rising sharply. On top of this a large number of branded drugs are listed to go off patent by 2016, giving pharmacies such as CVS Caremark Corporation the opportunity to push the use of generic products which offer higher profit margins. Investors can register for free to access the research report on CVS Caremark Corporation at www.stockcall.com/CVS151010.pdf.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information